Drug intelligence / Profile preview

Shugan Mianjian Keli

Development stage: Unknown
Administration: Oral

Overview

Shugan Mianjian Keli (疏肝免煎颗粒) is a Traditional Chinese Medicine (TCM) granule formulation. The name translates to "Liver-Soothing Decoction-Free Granules," indicating its primary function in TCM of soothing the liver and its ready-to-use granular form. It is designed to regulate qi, strengthen the spleen, and harmonize the stomach. The formulation described in a patent includes a combination of traditional Chinese herbs such as Chaihu (Bupleurum), Huangqin (Scutellaria), Jiang Banxia (Pinellia ternata), Dangshen (Codonopsis), Shengjiang (Ginger), Gancao (Licorice), Dazao (Jujube), Foshou (Bergamot), Muxiang (Costus root), Wuzhuyu (Evodia rutaecarpa), and Maiya (Malt).

Other names: 疏肝免煎颗粒

Beyond the preview

Go deeper on Shugan Mianjian Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shugan Mianjian Keli.

Explore the full profile